These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease]. Kujundzić M Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303 [TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis. Kaditis AG; Perrault J; Sandborn WJ; Landers CJ; Zinsmeister AR; Targan SR J Pediatr Gastroenterol Nutr; 1998 Apr; 26(4):386-92. PubMed ID: 9552133 [TBL] [Abstract][Full Text] [Related]
5. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Lohmuller JL; Pemberton JH; Dozois RR; Ilstrup D; van Heerden J Ann Surg; 1990 May; 211(5):622-7; discussion 627-9. PubMed ID: 2339922 [TBL] [Abstract][Full Text] [Related]
6. The diagnosis and treatment of pouchitis in inflammatory bowel disease. Cheifetz A; Itzkowitz S J Clin Gastroenterol; 2004; 38(5 Suppl 1):S44-50. PubMed ID: 15115932 [TBL] [Abstract][Full Text] [Related]
7. Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. Hoda KM; Collins JF; Knigge KL; Deveney KE Dis Colon Rectum; 2008 May; 51(5):554-60. PubMed ID: 18266037 [TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Sandborn WJ; Landers CJ; Tremaine WJ; Targan SR Am J Gastroenterol; 1995 May; 90(5):740-7. PubMed ID: 7733080 [TBL] [Abstract][Full Text] [Related]
9. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A; Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803 [TBL] [Abstract][Full Text] [Related]
10. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation. Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228 [TBL] [Abstract][Full Text] [Related]
11. [Joint disease in inflammatory bowel disease]. Paredes JM; Barrachina MM; Román J; Moreno-Osset E Gastroenterol Hepatol; 2005 Apr; 28(4):240-9. PubMed ID: 15811268 [TBL] [Abstract][Full Text] [Related]